Tower Research Capital LLC TRC Has $1.11 Million Stock Holdings in Revvity, Inc. (NYSE:RVTY)

Tower Research Capital LLC TRC boosted its holdings in shares of Revvity, Inc. (NYSE:RVTY) by 220.9% during the 4th quarter, Holdings Channel reports. The institutional investor owned 9,931 shares of the company’s stock after buying an additional 6,836 shares during the period. Tower Research Capital LLC TRC’s holdings in Revvity were worth $1,108,000 as of its most recent SEC filing.

Several other large investors have also recently bought and sold shares of the business. Victory Capital Management Inc. increased its stake in shares of Revvity by 17.4% in the fourth quarter. Victory Capital Management Inc. now owns 70,250 shares of the company’s stock worth $7,841,000 after acquiring an additional 10,390 shares during the last quarter. JPMorgan Chase & Co. increased its position in Revvity by 13.7% in the 3rd quarter. JPMorgan Chase & Co. now owns 344,115 shares of the company’s stock worth $43,961,000 after purchasing an additional 41,497 shares during the last quarter. Contravisory Investment Management Inc. increased its position in Revvity by 1,715.9% in the 4th quarter. Contravisory Investment Management Inc. now owns 69,186 shares of the company’s stock worth $7,722,000 after purchasing an additional 65,376 shares during the last quarter. Janney Montgomery Scott LLC raised its stake in shares of Revvity by 87.0% during the 4th quarter. Janney Montgomery Scott LLC now owns 7,891 shares of the company’s stock worth $881,000 after purchasing an additional 3,672 shares in the last quarter. Finally, Mirae Asset Global Investments Co. Ltd. lifted its holdings in shares of Revvity by 41.5% during the 4th quarter. Mirae Asset Global Investments Co. Ltd. now owns 12,072 shares of the company’s stock valued at $1,352,000 after buying an additional 3,542 shares during the last quarter. 86.65% of the stock is owned by institutional investors and hedge funds.

Insider Activity

In related news, insider Joel S. Goldberg sold 15,170 shares of the company’s stock in a transaction dated Thursday, January 30th. The shares were sold at an average price of $126.73, for a total value of $1,922,494.10. Following the sale, the insider now owns 33,400 shares of the company’s stock, valued at $4,232,782. The trade was a 31.23 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. 0.68% of the stock is currently owned by company insiders.

Wall Street Analysts Forecast Growth

Several equities analysts recently weighed in on the stock. Raymond James reaffirmed an “outperform” rating and set a $145.00 price objective (up previously from $140.00) on shares of Revvity in a research report on Monday, February 3rd. Robert W. Baird decreased their price objective on shares of Revvity from $141.00 to $127.00 and set an “outperform” rating for the company in a report on Monday. Barclays cut their target price on Revvity from $140.00 to $110.00 and set an “overweight” rating on the stock in a report on Thursday, April 10th. Wells Fargo & Company lowered their price objective on Revvity from $130.00 to $102.00 and set an “equal weight” rating on the stock in a report on Thursday, April 17th. Finally, KeyCorp boosted their target price on Revvity from $132.00 to $145.00 and gave the stock an “overweight” rating in a report on Monday, February 3rd. Four analysts have rated the stock with a hold rating, eight have issued a buy rating and one has given a strong buy rating to the stock. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average target price of $130.50.

Revvity Price Performance

NYSE:RVTY opened at $95.20 on Friday. The company has a debt-to-equity ratio of 0.41, a current ratio of 3.60 and a quick ratio of 3.03. Revvity, Inc. has a one year low of $88.53 and a one year high of $129.50. The company has a fifty day moving average price of $105.22 and a 200 day moving average price of $113.28. The stock has a market cap of $11.44 billion, a P/E ratio of 43.08, a PEG ratio of 3.82 and a beta of 1.07.

Revvity (NYSE:RVTY) last announced its quarterly earnings data on Friday, January 31st. The company reported $1.42 EPS for the quarter, beating analysts’ consensus estimates of $1.37 by $0.05. Revvity had a net margin of 9.81% and a return on equity of 7.68%. During the same quarter last year, the company earned $1.25 earnings per share. Analysts anticipate that Revvity, Inc. will post 4.94 earnings per share for the current year.

Revvity Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, August 8th. Stockholders of record on Friday, July 18th will be issued a dividend of $0.07 per share. This represents a $0.28 annualized dividend and a dividend yield of 0.29%. Revvity’s payout ratio is presently 12.67%.

Revvity Company Profile

Revvity, Inc provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market.